The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Djingle, my weighting in HCM isn't as great as yours but is around 50% of my portfolio. Still have a few more than intended. Should used some to trade with last year. Sold some and bought back in, timing hasn't been great, Initially bought at 1500 and added sold, bought gain since.